STEVENSON, Md.--(BUSINESS WIRE)--The law firm of Brower Piven, A Professional Corporation, is
investigating potential securities fraud claims against Celsion
Corporation (“Celsion”) (NASDAQ: CLSN) regarding whether Celsion may
have issued materially false or misleading information to investors
before announcing on January 31, 2013 that its ThermoDox liver cancer
treatment failed in a study and did not meet its primary endpoint.

If you purchased or acquired Celsion securities between January 1, 2012
and January 30, 2013 and have suffered a loss on your investment, or if
you believe you have information relating to the subject matter of our
investigation, you may email or call Brower Piven, who will, without
obligation or cost to you, communicate with you regarding the matter and
attempt to answer your questions. You may contact Brower Piven by email
at hoffman@browerpiven.com,
by calling 410/415-6616, or by writing to Brower Piven, A Professional
Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys
at Brower Piven have combined experience litigating securities and other
class action cases of over 60 years.

Recent Stories

STEVENSON, Md.--(EON: Enhanced Online News)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty ... more »

STEVENSON, Md.--(EON: Enhanced Online News)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty ... more »

STEVENSON, Md.--(EON: Enhanced Online News)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty ... more »